Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology
Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc
Bullboard Posts
User Avatar Image
(0)
•••
Post by viavidon Nov 24, 2000 12:27pm
224 Views
Post# 2884351

Conac Software Live & Interactive video chat

Conac Software Live & Interactive video chatConac Software Corporation LIVE and INTERACTIVE Video Chat Conference... This is not just an interview... so get involved and talk to Conac Software Corporation President and CEO, Jacqueline Michael. Make sure YOUR questions get answered live by Ms. Michael... these interactive conferences are a lot of fun. Join Samantha Sewell and Jacqueline Michael, Tuesday, November 28th, at 9:00AM PST for a LIVE and INTERACTIVE video chat conference. The conference will be broadcast live via streaming video and participants will be able to converse live with Samantha Sewell and Jacqueline Michael from the ViaVid website. It all takes place Tuesday, November 28th, at 9:00 AM PST at https://www.viavid.com E-mail your questions directly to the studio at talkback@viavid.com or directly off the website during the show. We look forward to seeing you there! If you miss the live program, the show will be archived on www.viavid.com for 1 month from the broadcast date. ViaVid Broadcasting Inc. is a leading edge technology company specializing in streaming media services over the Internet. ViaVid offers a variety of broadcasting services to public companies in the financial community. ViaVid hosts its own investment news show, VBC News1 hosted by Samantha Sewell. ViaVid is a content partner for the Microsoft Windows Media portal WindowsMedia.com. ViaVid is a newly listed (fully reporting) company on the OTC-BB under the symbol: VVDB
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities